BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1535164)

  • 1. Protection of glomerular filtration rate by the thromboxane receptor antagonist L655,240 during low dose cyclosporine administration.
    Bunke M; Wilder L; Martin A
    Prostaglandins; 1992 Apr; 43(4):351-60. PubMed ID: 1535164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cyclosporine on agonist-stimulated glomerular and mesangial cell vasodilatory prostaglandin production.
    Bunke M; Wilder L; Martin A
    Transplantation; 1991 Oct; 52(4):718-22. PubMed ID: 1926350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats.
    Spurney RF; Mayros SD; Collins D; Ruiz P; Klotman PE; Coffman T
    Prostaglandins; 1990 Feb; 39(2):135-46. PubMed ID: 2138344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-participation of thromboxane A2 and leukotriene C4 and D4 in mediating cyclosporine-induced acute renal failure.
    Perico N; Pasini M; Gaspari F; Abbate M; Remuzzi G
    Transplantation; 1991 Nov; 52(5):873-8. PubMed ID: 1835198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis.
    Stork JE; Dunn MJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):672-8. PubMed ID: 3859644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic cyclosporine administration on renal blood flow and intrarenal blood flow distribution.
    Youngelman DF; Kahng KU; Rosen BD; Dresner LS; Wait RB
    Transplantation; 1991 Feb; 51(2):503-9. PubMed ID: 1994546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesangial cell immune injury: effects of thromboxane receptor antagonism.
    Bresnahan BA; Roman RJ; Bagchus WM; Lianos EA
    J Am Soc Nephrol; 1991 Feb; 1(8):1041-7. PubMed ID: 1832980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for local prostaglandin and thromboxane production in the regulation of glomerular filtration rate in the rat with streptozocin-induced diabetes.
    Craven PA; DeRubertis FR
    J Lab Clin Med; 1989 Jun; 113(6):674-81. PubMed ID: 2525167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of prostaglandins and thromboxane in the control of renal hemodynamics in experimental liver cirrhosis.
    Leehey DJ; Uckerman MT; Rahman MA
    J Lab Clin Med; 1989 Mar; 113(3):309-15. PubMed ID: 2926239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity.
    Coffman TM; Carr DR; Yarger WE; Klotman PE
    Transplantation; 1987 Feb; 43(2):282-5. PubMed ID: 3810836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
    Lianos EA; Andres GA; Dunn MJ
    J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced glomerular thromboxane receptor sites and vasoconstrictor responses in diabetic rats.
    Wilkes BM; Kaplan R; Mento PF; Aynedjian HS; Macica CM; Schlondorff D; Bank N
    Kidney Int; 1992 Apr; 41(4):992-9. PubMed ID: 1387436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing.
    Bunke M; Sloan R; Brier M; Ganzel B
    Transplantation; 1995 Feb; 59(4):537-40. PubMed ID: 7878758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of thromboxane in two-kidney, one-clip Goldblatt hypertension in rats.
    Himmelstein SI; Klotman PE
    Am J Physiol; 1989 Aug; 257(2 Pt 2):F190-6. PubMed ID: 2527469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?
    Gossmann J; Radounikli A; Bernemann A; Schellinski O; Raab HP; Bickeböller R; Scheuermann EH
    Kidney Blood Press Res; 2001; 24(2):111-5. PubMed ID: 11435743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
    Yoo J; Schlondorff D; Neugarten J
    J Pharmacol Exp Ther; 1990 May; 253(2):743-8. PubMed ID: 2140130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of thromboxane production by acutely rejecting renal allografts in rats.
    Coffman TM; Yarger WE; Klotman PE
    J Clin Invest; 1985 Apr; 75(4):1242-8. PubMed ID: 3886703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine-induced hypertension in sheep. The role of thromboxanes.
    Tresham JJ; Whitworth JA; Scoggins BA; Bennett WM
    Transplantation; 1990 Jan; 49(1):144-8. PubMed ID: 2405549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane.
    dos Santos OF; Boim MA; Barros EJ; Pirotzky E; Braquet P; Schor N
    Lipids; 1991 Dec; 26(12):1320-3. PubMed ID: 1819724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ANG II, ETA, and TxA2 receptor antagonists on cyclosporin A renal vasoconstriction.
    Conger JD; Kim GE; Robinette JB
    Am J Physiol; 1994 Sep; 267(3 Pt 2):F443-9. PubMed ID: 8092258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.